We last checked in on Akorn, Inc. (NASDAQ:AKRX) in August and things were looking good. So, how did shares weather the market turmoil that was just ahead?
Company Description
Akorn, Inc. makes multisource and branded pharmaceuticals. The company specializes in diagnostics and therapeutic products, hospital drugs and injectable pharmaceuticals.
Another Surprise
On Nov 1 Akorn reported another great quarter. Earnings per share came in at $0.08, 3 cents better than expected. Revenues surged 70% to … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards